Mani, Inc.
Mani, Inc. 7730.T Peers
See (7730.T) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 7730.T | $1,226.00 | +2.00% | 120.8B | 20.01 | $61.26 | +3.24% |
| 7741.T | $17,925.00 | -0.80% | 6.1T | 30.15 | $594.50 | +0.89% |
| 4543.T | $2,721.00 | +0.29% | 4T | 34.46 | $78.95 | +0.96% |
| 7733.T | $1,792.50 | -0.44% | 2T | 17.45 | $102.74 | +1.11% |
| 6869.T | $2,457.00 | +1.05% | 1.5T | 28.57 | $86.00 | +1.32% |
| 7747.T | $2,250.00 | +0.92% | 611.2B | 58.00 | $38.79 | +0.91% |
| 8086.T | $1,242.50 | -0.40% | 202.6B | 44.66 | $27.82 | +2.57% |
| 3046.T | $8,670.00 | -0.12% | 202.4B | 29.91 | $289.91 | +1.05% |
| 3360.T | $1,843.50 | +2.19% | 173.9B | 11.33 | $162.72 | +3.22% |
| 7716.T | $1,872.00 | +2.30% | 157B | 28.02 | $66.80 | +2.84% |
Stock Comparison
7730.T vs 7741.T Comparison
7730.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7730.T stands at 120.8B. In comparison, 7741.T has a market cap of 6.1T. Regarding current trading prices, 7730.T is priced at $1,226.00, while 7741.T trades at $17,925.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7730.T currently has a P/E ratio of 20.01, whereas 7741.T's P/E ratio is 30.15. In terms of profitability, 7730.T's ROE is +0.11%, compared to 7741.T's ROE of +0.20%. Regarding short-term risk, 7730.T is more volatile compared to 7741.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7730.T.
7730.T vs 4543.T Comparison
7730.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7730.T stands at 120.8B. In comparison, 4543.T has a market cap of 4T. Regarding current trading prices, 7730.T is priced at $1,226.00, while 4543.T trades at $2,721.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7730.T currently has a P/E ratio of 20.01, whereas 4543.T's P/E ratio is 34.46. In terms of profitability, 7730.T's ROE is +0.11%, compared to 4543.T's ROE of +0.09%. Regarding short-term risk, 7730.T is less volatile compared to 4543.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7730.T.
7730.T vs 7733.T Comparison
7730.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7730.T stands at 120.8B. In comparison, 7733.T has a market cap of 2T. Regarding current trading prices, 7730.T is priced at $1,226.00, while 7733.T trades at $1,792.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7730.T currently has a P/E ratio of 20.01, whereas 7733.T's P/E ratio is 17.45. In terms of profitability, 7730.T's ROE is +0.11%, compared to 7733.T's ROE of +0.11%. Regarding short-term risk, 7730.T is more volatile compared to 7733.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7730.T.
7730.T vs 6869.T Comparison
7730.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7730.T stands at 120.8B. In comparison, 6869.T has a market cap of 1.5T. Regarding current trading prices, 7730.T is priced at $1,226.00, while 6869.T trades at $2,457.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7730.T currently has a P/E ratio of 20.01, whereas 6869.T's P/E ratio is 28.57. In terms of profitability, 7730.T's ROE is +0.11%, compared to 6869.T's ROE of +0.13%. Regarding short-term risk, 7730.T is more volatile compared to 6869.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7730.T.
7730.T vs 7747.T Comparison
7730.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7730.T stands at 120.8B. In comparison, 7747.T has a market cap of 611.2B. Regarding current trading prices, 7730.T is priced at $1,226.00, while 7747.T trades at $2,250.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7730.T currently has a P/E ratio of 20.01, whereas 7747.T's P/E ratio is 58.00. In terms of profitability, 7730.T's ROE is +0.11%, compared to 7747.T's ROE of +0.12%. Regarding short-term risk, 7730.T is less volatile compared to 7747.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7730.T.
7730.T vs 8086.T Comparison
7730.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7730.T stands at 120.8B. In comparison, 8086.T has a market cap of 202.6B. Regarding current trading prices, 7730.T is priced at $1,226.00, while 8086.T trades at $1,242.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7730.T currently has a P/E ratio of 20.01, whereas 8086.T's P/E ratio is 44.66. In terms of profitability, 7730.T's ROE is +0.11%, compared to 8086.T's ROE of +0.02%. Regarding short-term risk, 7730.T is more volatile compared to 8086.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7730.T.
7730.T vs 3046.T Comparison
7730.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7730.T stands at 120.8B. In comparison, 3046.T has a market cap of 202.4B. Regarding current trading prices, 7730.T is priced at $1,226.00, while 3046.T trades at $8,670.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7730.T currently has a P/E ratio of 20.01, whereas 3046.T's P/E ratio is 29.91. In terms of profitability, 7730.T's ROE is +0.11%, compared to 3046.T's ROE of +0.27%. Regarding short-term risk, 7730.T is more volatile compared to 3046.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7730.T.
7730.T vs 3360.T Comparison
7730.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7730.T stands at 120.8B. In comparison, 3360.T has a market cap of 173.9B. Regarding current trading prices, 7730.T is priced at $1,226.00, while 3360.T trades at $1,843.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7730.T currently has a P/E ratio of 20.01, whereas 3360.T's P/E ratio is 11.33. In terms of profitability, 7730.T's ROE is +0.11%, compared to 3360.T's ROE of +0.12%. Regarding short-term risk, 7730.T is more volatile compared to 3360.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7730.T.
7730.T vs 7716.T Comparison
7730.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7730.T stands at 120.8B. In comparison, 7716.T has a market cap of 157B. Regarding current trading prices, 7730.T is priced at $1,226.00, while 7716.T trades at $1,872.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7730.T currently has a P/E ratio of 20.01, whereas 7716.T's P/E ratio is 28.02. In terms of profitability, 7730.T's ROE is +0.11%, compared to 7716.T's ROE of +0.07%. Regarding short-term risk, 7730.T is less volatile compared to 7716.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7730.T.
7730.T vs 7817.T Comparison
7730.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7730.T stands at 120.8B. In comparison, 7817.T has a market cap of 138.2B. Regarding current trading prices, 7730.T is priced at $1,226.00, while 7817.T trades at $2,465.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7730.T currently has a P/E ratio of 20.01, whereas 7817.T's P/E ratio is 15.47. In terms of profitability, 7730.T's ROE is +0.11%, compared to 7817.T's ROE of +0.07%. Regarding short-term risk, 7730.T is more volatile compared to 7817.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7730.T.
7730.T vs 3593.T Comparison
7730.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7730.T stands at 120.8B. In comparison, 3593.T has a market cap of 84.3B. Regarding current trading prices, 7730.T is priced at $1,226.00, while 3593.T trades at $3,910.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7730.T currently has a P/E ratio of 20.01, whereas 3593.T's P/E ratio is 57.65. In terms of profitability, 7730.T's ROE is +0.11%, compared to 3593.T's ROE of +0.02%. Regarding short-term risk, 7730.T is more volatile compared to 3593.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7730.T.
7730.T vs 7780.T Comparison
7730.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7730.T stands at 120.8B. In comparison, 7780.T has a market cap of 82.2B. Regarding current trading prices, 7730.T is priced at $1,226.00, while 7780.T trades at $1,081.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7730.T currently has a P/E ratio of 20.01, whereas 7780.T's P/E ratio is 15.63. In terms of profitability, 7730.T's ROE is +0.11%, compared to 7780.T's ROE of +0.06%. Regarding short-term risk, 7730.T is more volatile compared to 7780.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7730.T.
7730.T vs 7979.T Comparison
7730.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7730.T stands at 120.8B. In comparison, 7979.T has a market cap of 76.7B. Regarding current trading prices, 7730.T is priced at $1,226.00, while 7979.T trades at $2,157.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7730.T currently has a P/E ratio of 20.01, whereas 7979.T's P/E ratio is 17.24. In terms of profitability, 7730.T's ROE is +0.11%, compared to 7979.T's ROE of +0.11%. Regarding short-term risk, 7730.T is more volatile compared to 7979.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7730.T.
7730.T vs 5889.T Comparison
7730.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7730.T stands at 120.8B. In comparison, 5889.T has a market cap of 54.1B. Regarding current trading prices, 7730.T is priced at $1,226.00, while 5889.T trades at $2,242.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7730.T currently has a P/E ratio of 20.01, whereas 5889.T's P/E ratio is 13.74. In terms of profitability, 7730.T's ROE is +0.11%, compared to 5889.T's ROE of +0.27%. Regarding short-term risk, 7730.T is more volatile compared to 5889.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7730.T.
7730.T vs 7749.T Comparison
7730.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7730.T stands at 120.8B. In comparison, 7749.T has a market cap of 36.5B. Regarding current trading prices, 7730.T is priced at $1,226.00, while 7749.T trades at $2,499.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7730.T currently has a P/E ratio of 20.01, whereas 7749.T's P/E ratio is 12.21. In terms of profitability, 7730.T's ROE is +0.11%, compared to 7749.T's ROE of +0.07%. Regarding short-term risk, 7730.T is more volatile compared to 7749.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7730.T.
7730.T vs 3154.T Comparison
7730.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7730.T stands at 120.8B. In comparison, 3154.T has a market cap of 21.2B. Regarding current trading prices, 7730.T is priced at $1,226.00, while 3154.T trades at $952.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7730.T currently has a P/E ratio of 20.01, whereas 3154.T's P/E ratio is 20.72. In terms of profitability, 7730.T's ROE is +0.11%, compared to 3154.T's ROE of +0.05%. Regarding short-term risk, 7730.T is more volatile compared to 3154.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7730.T.
7730.T vs 7743.T Comparison
7730.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7730.T stands at 120.8B. In comparison, 7743.T has a market cap of 13.4B. Regarding current trading prices, 7730.T is priced at $1,226.00, while 7743.T trades at $444.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7730.T currently has a P/E ratio of 20.01, whereas 7743.T's P/E ratio is 7.11. In terms of profitability, 7730.T's ROE is +0.11%, compared to 7743.T's ROE of +0.09%. Regarding short-term risk, 7730.T is more volatile compared to 7743.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7730.T.
7730.T vs 7775.T Comparison
7730.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7730.T stands at 120.8B. In comparison, 7775.T has a market cap of 12.6B. Regarding current trading prices, 7730.T is priced at $1,226.00, while 7775.T trades at $438.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7730.T currently has a P/E ratio of 20.01, whereas 7775.T's P/E ratio is 11.88. In terms of profitability, 7730.T's ROE is +0.11%, compared to 7775.T's ROE of +0.15%. Regarding short-term risk, 7730.T is more volatile compared to 7775.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7730.T.
7730.T vs 7702.T Comparison
7730.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7730.T stands at 120.8B. In comparison, 7702.T has a market cap of 10.5B. Regarding current trading prices, 7730.T is priced at $1,226.00, while 7702.T trades at $428.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7730.T currently has a P/E ratio of 20.01, whereas 7702.T's P/E ratio is -289.19. In terms of profitability, 7730.T's ROE is +0.11%, compared to 7702.T's ROE of +0.00%. Regarding short-term risk, 7730.T is more volatile compared to 7702.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7730.T.
7730.T vs 3604.T Comparison
7730.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7730.T stands at 120.8B. In comparison, 3604.T has a market cap of 6.9B. Regarding current trading prices, 7730.T is priced at $1,226.00, while 3604.T trades at $1,198.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7730.T currently has a P/E ratio of 20.01, whereas 3604.T's P/E ratio is 15.04. In terms of profitability, 7730.T's ROE is +0.11%, compared to 3604.T's ROE of +0.07%. Regarding short-term risk, 7730.T is more volatile compared to 3604.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7730.T.
7730.T vs 3446.T Comparison
7730.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7730.T stands at 120.8B. In comparison, 3446.T has a market cap of 6.6B. Regarding current trading prices, 7730.T is priced at $1,226.00, while 3446.T trades at $1,129.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7730.T currently has a P/E ratio of 20.01, whereas 3446.T's P/E ratio is 34.86. In terms of profitability, 7730.T's ROE is +0.11%, compared to 3446.T's ROE of +0.08%. Regarding short-term risk, 7730.T is more volatile compared to 3446.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7730.T.
7730.T vs 7980.T Comparison
7730.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7730.T stands at 120.8B. In comparison, 7980.T has a market cap of 5.6B. Regarding current trading prices, 7730.T is priced at $1,226.00, while 7980.T trades at $782.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7730.T currently has a P/E ratio of 20.01, whereas 7980.T's P/E ratio is 8.20. In terms of profitability, 7730.T's ROE is +0.11%, compared to 7980.T's ROE of +0.08%. Regarding short-term risk, 7730.T is more volatile compared to 7980.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7730.T.
7730.T vs 9340.T Comparison
7730.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7730.T stands at 120.8B. In comparison, 9340.T has a market cap of 5.5B. Regarding current trading prices, 7730.T is priced at $1,226.00, while 9340.T trades at $566.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7730.T currently has a P/E ratio of 20.01, whereas 9340.T's P/E ratio is 12.02. In terms of profitability, 7730.T's ROE is +0.11%, compared to 9340.T's ROE of +0.17%. Regarding short-term risk, 7730.T is more volatile compared to 9340.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7730.T.
7730.T vs 4556.T Comparison
7730.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7730.T stands at 120.8B. In comparison, 4556.T has a market cap of 5.2B. Regarding current trading prices, 7730.T is priced at $1,226.00, while 4556.T trades at $1,232.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7730.T currently has a P/E ratio of 20.01, whereas 4556.T's P/E ratio is 8.47. In terms of profitability, 7730.T's ROE is +0.11%, compared to 4556.T's ROE of +0.09%. Regarding short-term risk, 7730.T is more volatile compared to 4556.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7730.T.
7730.T vs 7782.T Comparison
7730.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7730.T stands at 120.8B. In comparison, 7782.T has a market cap of 4B. Regarding current trading prices, 7730.T is priced at $1,226.00, while 7782.T trades at $619.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7730.T currently has a P/E ratio of 20.01, whereas 7782.T's P/E ratio is 13.11. In terms of profitability, 7730.T's ROE is +0.11%, compared to 7782.T's ROE of +0.12%. Regarding short-term risk, 7730.T is less volatile compared to 7782.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7730.T.
7730.T vs 7813.T Comparison
7730.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7730.T stands at 120.8B. In comparison, 7813.T has a market cap of 2.6B. Regarding current trading prices, 7730.T is priced at $1,226.00, while 7813.T trades at $742.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7730.T currently has a P/E ratio of 20.01, whereas 7813.T's P/E ratio is 30.35. In terms of profitability, 7730.T's ROE is +0.11%, compared to 7813.T's ROE of +0.03%. Regarding short-term risk, 7730.T is more volatile compared to 7813.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7730.T.
7730.T vs 7090.T Comparison
7730.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7730.T stands at 120.8B. In comparison, 7090.T has a market cap of 1.5B. Regarding current trading prices, 7730.T is priced at $1,226.00, while 7090.T trades at $1,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7730.T currently has a P/E ratio of 20.01, whereas 7090.T's P/E ratio is 14.87. In terms of profitability, 7730.T's ROE is +0.11%, compared to 7090.T's ROE of -0.20%. Regarding short-term risk, 7730.T is more volatile compared to 7090.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7730.T.